Honeywell

HON

Market cap $151B

Honeywell International Inc. (HON) closed the most recent trading day at $237.86, moving +2.09% from the previous trading session.

Investors looking for stocks in the Diversified Operations sector might want to consider either Sumitomo Corp. (SSUMY) or Honeywell International Inc. (HON). But which of these two stocks presents investors with the better value opportunity right now?

The industrial company is carving out its quantum computing unit into a separate company. This will make that business, Quantinuum, one of the few pure-play quantum stocks on the market.

The IPO market is waking up again, and few offerings have generated as much buzz as SpaceX.

Honeywell's Quantinuum is targeting a valuation of up to $12.7 billion in its U.S. initial public offering, it ​said on Tuesday, as it looks to capitalize on ‌heightened investor attention around quantum computing.

Honeywell International NASDAQ: HON is on track to complete its planned separation on June 29, the first day of the third quarter, Chief Financial Officer and Senior Vice President Mike Stepniak said at an investor conference.

Honeywell to help address critical building needs and improve the fan experience across NHL arenas, practice facilities and community rinks ATLANTA and NEW YORK, May 20, 2026 /PRNewswire/ -- Honeywell (NASDAQ: HON) and the National Hockey League (NHL) today announced a new multi‑year global partnership naming Honeywell the Official Building Automation and Energy Management Partner of the NHL. Under the agreement, Honeywell will support the NHL's efforts of modernizing and creating more resilient, energy efficient arenas, practice facilities and community rinks across North America.

Honeywell International Inc. (HON) Presents at Wolfe Research 19th Annual Global Transportation & Industrials Conference Transcript

Investor expectations for pure-play stocks like RTX tend to be more straightforward than those of companies with a lot of moving parts. Honeywell's spinoffs could pay off even if it gets removed from the Dow.

Valvoline was Broyhill's largest contributor in the quarter, as the underlying unit economics are intact, while unit growth, service mix, and price continue moving in the same direction. Honeywell management accelerated the aerospace spin-off to the end of June, leaving behind a pure-play automation business that Broyhill believes is worth meaningfully more than the whole. Large pharma is structurally reliant on IQVIA's clinical trial architecture and proprietary data assets, and Broyhill thinks it is highly unlikely that AI can automate away the FDA approval process.